A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy — ARDA

Multifocal Motor Neuropathy Clinical Trial

Official title:
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy

Status Active, not recruiting

Clinical Trial Summary

This is a phase 2, randomized, double-blinded, placebo-controlled, parallel-group, multicenter trial to evaluate the safety and efficacy of 2 dose regimens of ARGX-117 versus placebo, in participants with MMN previously stabilized with IVIg (intravenous immunoglobulin).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05225675
Study type	Interventional
Source	argenx
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	March 31, 2022
Completion date	October 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06040567` - Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Not yet recruiting	`NCT02885259` - HyQvia in Multifocal Motor Neuropathy	N/A
Active, not recruiting	`NCT01655394` - Change of Nerve Conduction Properties in IVIg Dependent Neuropathies	N/A
Recruiting	`NCT05988073` - A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
Completed	`NCT02556437` - Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)	Phase 2
Completed	`NCT02111590` - Immunoglobulin Dosage and Administration Form in CIDP and MMN	N/A
Completed	`NCT00666263` - Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy	Phase 3
Completed	`NCT00268788` - Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy	Phase 2
Completed	`NCT02121678` - Effect of Resistance and Aerobic Exercise in CIDP or MMN	N/A
Completed	`NCT01827072` - Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.	Phase 3